The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma. [electronic resource]
Producer: 20190227Description: 905-921.e5 p. digitalISSN:- 1878-3686
- Animals
- Benzeneacetamides -- administration & dosage
- Boron Compounds -- administration & dosage
- Carcinoma, Squamous Cell -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Gene Expression Regulation, Neoplastic -- drug effects
- Glutamine -- metabolism
- Glycine -- administration & dosage
- Glycogen Synthase Kinase 3 -- metabolism
- Glycolysis
- Humans
- Ki-67 Antigen -- genetics
- Lung Neoplasms -- drug therapy
- Mice
- Neoplasm Transplantation
- Signal Transduction -- drug effects
- Thiadiazoles -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.